# Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery

> **NCT04025840** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 260 (actual)

## Conditions studied

- Pancreatic Cancer
- Surgery
- Epidural Block
- Dexamethasone
- Overall Survival

## Interventions

- **OTHER:** Epidural block
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT04025840
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-09-11
- **Primary completion:** 2024-10-22
- **Final completion:** 2026-11
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04025840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04025840, "Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04025840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*